Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases

被引：0
作者：
Jui-Ming Liu
Cheng-Ping Yu
Heng-Chang Chuang
Chun-Te Wu
Ren-Jun Hsu
机构：
[1] Ministry of Health and Welfare,Division of Urology, Department of Surgery, Taoyuan General Hospital
[2] National Yang-Ming University,Faculty of Medicine
[3] National Defense Medical Center,Graduate Institute of Life Sciences
[4] National Defense Medical Center,Department of Pathology and Graduate Institute of Pathology and Parasitology, Tri
[5] Chang Gung Memorial Hospital,Service General Hospital
[6] Tzu Chi University,Department of Urology
来源：
Prostate Cancer and Prostatic Diseases | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：475 / 482
页数：7
相关论文
共 50 条
  • [1] Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases
    Liu, Jui-Ming
    Yu, Cheng-Ping
    Chuang, Heng-Chang
    Wu, Chun-Te
    Hsu, Ren-Jun
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (03) : 475 - 482
  • [2] ANDROGEN DEPRIVATION THERAPY AND THE RISK OF RHEUMATIC AUTOIMMUNE DISEASES IN OLDER MEN WITH PROSTATE CANCER
    Albayyaa, M.
    Digbeu, B.
    Baillargeon, J.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2024, 20 (04) : E98 - E99
  • [3] Androgen Deprivation Therapy and the Incidence of Autoimmune Diseases in Patients with Prostate Cancer
    Klil-Drori, Adi J.
    Tascilar, Koray
    Yin, Hui
    Aprikian, Armen
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 309 - 310
  • [4] Androgen deprivation therapy for prostate cancer and the risk of thyroid diseases
    Liu, Jui-Ming
    Chen, Yu-Tang
    Wu, Chun-Te
    Hsu, Wen-Lin
    Hsu, Ren-Jun
    PROSTATE, 2022, 82 (07) : 809 - 815
  • [5] ANDROGEN DEPRIVATION THERAPY AND THE INCIDENCE OF AUTOIMMUNE DISEASES IN 17,168 PATIENTS WITH PROSTATE CANCER
    Liu, Jui-Ming
    Chuang, Heng-Chang
    Wu, Chun-Te
    Hsu, Ren-Jun
    JOURNAL OF UROLOGY, 2017, 197 (04) : E674 - E675
  • [6] Androgen deprivation therapy in high risk prostate cancer
    Van Dams, Ritchell
    Kishan, Amar U.
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 2216 - 2217
  • [7] Androgen deprivation therapy for prostate cancer and osteoporotic risk
    Cortet, B.
    Lartigau, E.
    Caty, A.
    Moulinier, F.
    Staerman, F.
    Villamizar-Vesga, J.
    Villers, A.
    PROGRES EN UROLOGIE, 2012, 22 : S31 - S38
  • [8] Androgen deprivation therapy for prostate cancer and risk of dementia
    Robinson, David
    Garmo, Hans
    Van Hemelrijck, Mieke
    Damber, Jan-Erik
    Bratt, Ola
    Holmberg, Lars
    Wahlund, Lars-Olof
    Stattin, Par
    Adolfsson, Jan
    BJU INTERNATIONAL, 2019, 124 (01) : 87 - 92
  • [9] Androgen deprivation therapy and cardiovascular risk in prostate cancer
    DE Nunzio, Cosimo
    Fiori, Cristian
    Fusco, Ferdinando
    Gregori, Andrea
    Pagliarulo, Vincenzo
    Alongi, Filippo
    MINERVA UROLOGY AND NEPHROLOGY, 2022, 74 (05): : 508 - 517
  • [10] Androgen deprivation therapy and risk of diabetes mellitus in men undergoing androgen deprivation therapy for prostate cancer
    Kincade, MC
    Derweesh, IH
    Malcolm, J
    Lamar, KD
    Patterson, AL
    Kitabchi, AE
    Wake, R
    JOURNAL OF UROLOGY, 2006, 175 (04) : 41 - 41
12345